These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22114492)

  • 41. Evaluation of therapeutic effectiveness of (131)I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer.
    Li W; Ji YH; Li CX; Liu ZY; Li N; Fang L; Chang J; Tan J
    World J Gastroenterol; 2016 Apr; 22(14):3758-68. PubMed ID: 27076760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
    Rangger C; Helbok A; Sosabowski J; Kremser C; Koehler G; Prassl R; Andreae F; Virgolini IJ; von Guggenberg E; Decristoforo C
    Int J Nanomedicine; 2013; 8():4659-71. PubMed ID: 24353415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer.
    Iinuma H; Maruyama K; Okinaga K; Sasaki K; Sekine T; Ishida O; Ogiwara N; Johkura K; Yonemura Y
    Int J Cancer; 2002 May; 99(1):130-7. PubMed ID: 11948504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
    Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW
    Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biodistribution, Pharmacokinetics and Efficacy of
    Chen LC; Lee WC; Ho CL; Chang YJ; Chen SJ; Chang CH
    In Vivo; 2018; 32(3):567-573. PubMed ID: 29695562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse.
    Konishi H; Takagi A; Kurita A; Kaneda N; Matsuzaki T
    BMC Cancer; 2012 Oct; 12():462. PubMed ID: 23046546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin.
    Li G; Wang Y; Huang K; Zhang H; Peng W; Zhang C
    Nucl Med Biol; 2005 Jan; 32(1):59-65. PubMed ID: 15691662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
    Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
    Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorbed doses in humans from
    Azadbakht B; Afarideh H; Ghannadi-Maragheh M; Bahrami-Samani A; Yousefnia H
    Appl Radiat Isot; 2018 Jan; 131():96-102. PubMed ID: 29173814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis.
    Lin WY; Tsai SC; Hsieh BT; Lee TW; Ting G; Wang SJ
    J Nucl Cardiol; 2000; 7(1):37-42. PubMed ID: 10698233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
    Häfeli UO; Casillas S; Dietz DW; Pauer GJ; Rybicki LA; Conzone SD; Day DE
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):189-99. PubMed ID: 10219814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and preliminary evaluation of n.c.a. iodoquine: a novel radiotracer with high uptake in cells with high ALDH1 expression.
    Chin BB; Hjelemand A; Rich J; Song H; Lascola C; Storms R; McLendon R; Reiman R; Greer KL; Metzler SD; McDougald D; Dai D; Vaidyanathan G
    Curr Radiopharm; 2012 Jan; 5(1):47-58. PubMed ID: 21864242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice.
    Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW
    Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiopharmacokinetic and dosimetric parameters of 188Re-lanreotide in athymic mice with induced human cancer tumors.
    Molina-Trinidad EM; de Murphy CA; Ferro-Flores G; Murphy-Stack E; Jung-Cook H
    Int J Pharm; 2006 Mar; 310(1-2):125-30. PubMed ID: 16423478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FF-10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model.
    Higuchi T; Yokobori T; Takahashi R; Naito T; Kitahara H; Matsumoto T; Kakinuma C; Hagiwara S; Kuwano H; Shirabe K; Asao T
    Cancer Sci; 2019 Sep; 110(9):2933-2940. PubMed ID: 31278877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancing Treatment Efficacy of
    Kuo HT; Merkens H; Zhang Z; Uribe CF; Lau J; Zhang C; Colpo N; Lin KS; Bénard F
    Mol Pharm; 2018 Nov; 15(11):5183-5191. PubMed ID: 30251544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.